Jiangsu Topcel-kh Pharmaceutical Co., Ltd.

This early-stage trial tests a new type of CAR-T cell therapy called BAFF-R CAR-T for adults with a specific kind of B-cell lymphoma that has stopped responding to treatment and does not have the CD19 marker. The study will enroll 30 people to see if the treatment is safe and tol…

This early study tests a new type of immune cell therapy called anti-PD1 armored CD19 CAR-T cells in 30 adults with diffuse large B-cell lymphoma that has come back or not responded to treatment. The cells are designed to better attack cancer and resist exhaustion. The main goal …